99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP, HACCP
  • 99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
  • 99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
  • 99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
  • 99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
  • 99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
  • 99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
Find Similar Products
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Abarelix
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Adult
State
Powder
Purity
>99%
Product Name
Abarelix
Name
Abarelix Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
183552-38-7
Mf
C72h95cln14o14
MW
1416.0631
Density
1.286
Boiling Point
1688.4°cat760mmhg
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
1000kg/Month

Product Description

99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
Product Description
99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
Product Details
99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
Product name Abarelix
Appearance White powder
CAS NO. 183552-38-7
MF C72H95ClN14O14
MW 1416.0631
Abarelix is an antagonist of releasing-hormone (Gn RH) receptor, and it was launched as an intramuscular injection for the palliative treatment of advanced symptomatic prostate cancer. Abarelix is a decapeptide, and it is prepared by a typical coupling cycle for peptide synthesis using Boc-amino acids and a methylbenzhydrylamine (MBHA) resin.
Application&Function
99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix

It's an antitumor agent, is currently the first approved storable formulation of a releasing hormone antagonist and the first new type of prostate cancer agent.

Specification

99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix
99% CAS 183552-38-7 Plenaxis Abarelix Powder Abarelix Acetate Abarelix

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier